Report

Ascencio: H1 figures


5,3% gross dividend yield


Underlying
Ascendis Health Ltd

Ascendis Health Limited is a health and care brands company. The Company operates through four segments: Consumer Brands, Pharma-Med, Phyto-Vet and International. Its Consumer Brands segment consists of health and personal care products sold to the public, primarily at the retail store level. It offers over the counter (OTC) medicines and consumer brands products, including vitamins and minerals, homeopathic, herbal products, dermaceuticals, functional foods, functional super foods, sports nutrition, health beverages, weight management and therapeutic cosmetics. Its Pharma-Med segment consists of the sale of prescription and selected OTC pharmaceuticals, and includes medical devices. The Phyto-Vet segment supplies health and care products to the plant and animal markets. It manufactures and supplies over 3,500 products. The International segment sells health and personal care products, prescription and selected OTC pharmaceuticals and medical devices operating in the European market.

Provider
BVBA Demes
BVBA Demes

​Gert De Mesure (Bvba Demes) has more than 25 years experience in financial markets, of which more than 20 years in buy/sell-side research (Bank Delen, Delta Lloyd Securities and as an independent analyst). He is specialised in Belgian small- and mid-caps, as well as in Belgian REITs.

Other Reports on these Companies
Other Reports from BVBA Demes

ResearchPool Subscriptions

Get the most out of your insights

Get in touch